Close Menu

NEW YORK – Diagnostic firm SpeeDx announced Tuesday a partnership with Roche to expand global access to the firm's infectious disease and antibiotic resistance tests and technology.

Under the non-exclusive agreement, Roche will have access to SpeeDx's existing tests and technology, expanding patient access to diagnostic products, including new ones, for the management of antibiotic resistance in sexually transmitted infections, the firm said in a statement.

Financial and other terms of the deal were not disclosed. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.